Monitoring and treatment of anti-D in pregnancy

D Bettelheim; S Panzer; H W Reesink; B Csapo; C Pessoa; F Guerra; S Wendel; P Calda; U Sprogøe; M Dziegiel; A Aitokallio-Tallberg; S Koskinen; M Kuosmanen; T J Legler; W Stein; S Villa; M A Villa; L Trespidi; B Acaia; F P H A Vandenbussche; A Brand; M de Haas; H H H Kanhai; D Gounder; P Flanagan; R Donegan; E Parry; C Sefonte; S M Skulstad; T Hervig; Ø Flesland; B Zupańska; M Uhrynowska; O Lapaire; X Y Zhong; W Holzgreve

doi:10.1111/j.1423-0410.2010.01322.x

Monitoring and treatment of anti-D in pregnancy

D Bettelheim, S Panzer, H W Reesink, B Csapo, C Pessoa, F Guerra, S Wendel, P Calda, U Sprogøe, M Dziegiel, A Aitokallio-Tallberg, S Koskinen, M Kuosmanen, T J Legler, W Stein, S Villa, M A Villa, L Trespidi, B Acaia, F P H A VandenbusscheA Brand, M de Haas, H H H Kanhai, D Gounder, P Flanagan, R Donegan, E Parry, C Sefonte, S M Skulstad, T Hervig, Ø Flesland, B Zupańska, M Uhrynowska, O Lapaire, X Y Zhong, W Holzgreve

Afdeling for Klinisk Immunologi

8 Citationer (Scopus)

Abstract

Prophylactic anti-D is a very safe and effective therapy for the suppression of anti-D immunization and thus prevention of haemolytic disease of the foetus and newborn. However, migration from countries with low health standards and substantial cuts in public health expenses have increased the incidence of anti-D immunization in many "developed" countries. Therefore, this forum focuses on prenatal monitoring standards and treatment strategies in pregnancies with anti-D alloimmunization. The following questions were addressed, and a response was obtained from 12 centres, mainly from Europe.

Originalsprog	Engelsk
Tidsskrift	Vox Sanguinis
Vol/bind	99
Udgave nummer	2
Sider (fra-til)	177-92
Antal sider	16
ISSN	0042-9007
DOI	https://doi.org/10.1111/j.1423-0410.2010.01322.x
Status	Udgivet - 1 aug. 2010

Adgang til dokumentet

10.1111/j.1423-0410.2010.01322.x

Citationsformater

Bettelheim, D., Panzer, S., Reesink, H. W., Csapo, B., Pessoa, C., Guerra, F., Wendel, S., Calda, P., Sprogøe, U., Dziegiel, M., Aitokallio-Tallberg, A., Koskinen, S., Kuosmanen, M., Legler, T. J., Stein, W., Villa, S., Villa, M. A., Trespidi, L., Acaia, B., ... Holzgreve, W. (2010). Monitoring and treatment of anti-D in pregnancy. Vox Sanguinis, 99(2), 177-92. https://doi.org/10.1111/j.1423-0410.2010.01322.x

Bettelheim, D, Panzer, S, Reesink, HW, Csapo, B, Pessoa, C, Guerra, F, Wendel, S, Calda, P, Sprogøe, U, Dziegiel, M, Aitokallio-Tallberg, A, Koskinen, S, Kuosmanen, M, Legler, TJ, Stein, W, Villa, S, Villa, MA, Trespidi, L, Acaia, B, Vandenbussche, FPHA, Brand, A, de Haas, M, Kanhai, HHH, Gounder, D, Flanagan, P, Donegan, R, Parry, E, Sefonte, C, Skulstad, SM, Hervig, T, Flesland, Ø, Zupańska, B, Uhrynowska, M, Lapaire, O, Zhong, XY & Holzgreve, W 2010, 'Monitoring and treatment of anti-D in pregnancy', Vox Sanguinis, bind 99, nr. 2, s. 177-92. https://doi.org/10.1111/j.1423-0410.2010.01322.x

@article{01425fd7279b456998d88171c8360262,

title = "Monitoring and treatment of anti-D in pregnancy",

abstract = "Prophylactic anti-D is a very safe and effective therapy for the suppression of anti-D immunization and thus prevention of haemolytic disease of the foetus and newborn. However, migration from countries with low health standards and substantial cuts in public health expenses have increased the incidence of anti-D immunization in many {"}developed{"} countries. Therefore, this forum focuses on prenatal monitoring standards and treatment strategies in pregnancies with anti-D alloimmunization. The following questions were addressed, and a response was obtained from 12 centres, mainly from Europe.",

keywords = "Blood Group Antigens/immunology, Female, Fetal Blood/immunology, Fetal Hemoglobin/analysis, Humans, Isoantibodies/administration & dosage, Pregnancy, Pregnancy Complications, Hematologic/blood, Rh Isoimmunization/immunology, Rh-Hr Blood-Group System/immunology, Rho(D) Immune Globulin",

author = "D Bettelheim and S Panzer and Reesink, {H W} and B Csapo and C Pessoa and F Guerra and S Wendel and P Calda and U Sprog{\o}e and M Dziegiel and A Aitokallio-Tallberg and S Koskinen and M Kuosmanen and Legler, {T J} and W Stein and S Villa and Villa, {M A} and L Trespidi and B Acaia and Vandenbussche, {F P H A} and A Brand and {de Haas}, M and Kanhai, {H H H} and D Gounder and P Flanagan and R Donegan and E Parry and C Sefonte and Skulstad, {S M} and T Hervig and {\O} Flesland and B Zupa{\'n}ska and M Uhrynowska and O Lapaire and Zhong, {X Y} and W Holzgreve",

year = "2010",

month = aug,

day = "1",

doi = "10.1111/j.1423-0410.2010.01322.x",

language = "English",

volume = "99",

pages = "177--92",

journal = "Vox Sanguinis",

issn = "0042-9007",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

TY - JOUR

T1 - Monitoring and treatment of anti-D in pregnancy

AU - Bettelheim, D

AU - Panzer, S

AU - Reesink, H W

AU - Csapo, B

AU - Pessoa, C

AU - Guerra, F

AU - Wendel, S

AU - Calda, P

AU - Sprogøe, U

AU - Dziegiel, M

AU - Aitokallio-Tallberg, A

AU - Koskinen, S

AU - Kuosmanen, M

AU - Legler, T J

AU - Stein, W

AU - Villa, S

AU - Villa, M A

AU - Trespidi, L

AU - Acaia, B

AU - Vandenbussche, F P H A

AU - Brand, A

AU - de Haas, M

AU - Kanhai, H H H

AU - Gounder, D

AU - Flanagan, P

AU - Donegan, R

AU - Parry, E

AU - Sefonte, C

AU - Skulstad, S M

AU - Hervig, T

AU - Flesland, Ø

AU - Zupańska, B

AU - Uhrynowska, M

AU - Lapaire, O

AU - Zhong, X Y

AU - Holzgreve, W

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Prophylactic anti-D is a very safe and effective therapy for the suppression of anti-D immunization and thus prevention of haemolytic disease of the foetus and newborn. However, migration from countries with low health standards and substantial cuts in public health expenses have increased the incidence of anti-D immunization in many "developed" countries. Therefore, this forum focuses on prenatal monitoring standards and treatment strategies in pregnancies with anti-D alloimmunization. The following questions were addressed, and a response was obtained from 12 centres, mainly from Europe.

AB - Prophylactic anti-D is a very safe and effective therapy for the suppression of anti-D immunization and thus prevention of haemolytic disease of the foetus and newborn. However, migration from countries with low health standards and substantial cuts in public health expenses have increased the incidence of anti-D immunization in many "developed" countries. Therefore, this forum focuses on prenatal monitoring standards and treatment strategies in pregnancies with anti-D alloimmunization. The following questions were addressed, and a response was obtained from 12 centres, mainly from Europe.

KW - Blood Group Antigens/immunology

KW - Female

KW - Fetal Blood/immunology

KW - Fetal Hemoglobin/analysis

KW - Humans

KW - Isoantibodies/administration & dosage

KW - Pregnancy

KW - Pregnancy Complications, Hematologic/blood

KW - Rh Isoimmunization/immunology

KW - Rh-Hr Blood-Group System/immunology

KW - Rho(D) Immune Globulin

U2 - 10.1111/j.1423-0410.2010.01322.x

DO - 10.1111/j.1423-0410.2010.01322.x

M3 - Journal article

C2 - 20331536

SN - 0042-9007

VL - 99

SP - 177

EP - 192

JO - Vox Sanguinis

JF - Vox Sanguinis

IS - 2

ER -

Monitoring and treatment of anti-D in pregnancy

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater